论文信息 - A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110). - 字舞流文

A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110).

M. Satouchi | T. Nishimura | S. Morita | F. Imamura | S. Negoro | N. Katakami | A. Hata | Y. Urata | T. Kumagai | C. Okuda | M. Tachihara | K. Nishino | Y. Hattori | Souichirou Yokota | T. Kaneda | Toshihiko Kaneda | Y. Hattori